Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts
- 1 July 2004
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 165 (1), 35-52
- https://doi.org/10.1016/s0002-9440(10)63273-7
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanismsThe FASEB Journal, 2003
- Antiangiogenic Therapy: More Promise and, Yet Again, More QuestionsJournal of Clinical Oncology, 2003
- Endothelial-pericyte interactions in angiogenesisCell and tissue research, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implicationsSeminars in Oncology, 2002
- Three-dimensional Cytoarchitecture of Angiogenic Blood Vessels in a Gelatin Sheet Implanted in the Rat Skeletal Muscular Layers.Archives of Histology and Cytology, 2002
- Genes Expressed in Human Tumor EndotheliumScience, 2000
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenesNature, 1985